gms | German Medical Science

67. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e. V. (GMDS), 13. Jahreskongress der Technologie- und Methodenplattform für die vernetzte medizinische Forschung e. V. (TMF)

21.08. - 25.08.2022, online

Bayesian regions of evidence (for normal distributions)

Meeting Abstract

Search Medline for

  • Robert Miller - Pfizer Pharma GmbH, Berlin, Germany; Technische Universität Dresden, Dresden, Germany
  • Michael Höfler - Technische Universität Dresden, Dresden, Germany

Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie. 67. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e. V. (GMDS), 13. Jahreskongress der Technologie- und Methodenplattform für die vernetzte medizinische Forschung e.V. (TMF). sine loco [digital], 21.-25.08.2022. Düsseldorf: German Medical Science GMS Publishing House; 2022. DocAbstr. 116

doi: 10.3205/22gmds088, urn:nbn:de:0183-22gmds0887

Published: August 19, 2022

© 2022 Miller et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Bayesian inference allows to assess whether a claim about an effect (e.g., effect > 0, effect > Δ, |effect| < Δ) is justified given the (likelihood of the) data and a prior distribution that quantifies an individual’s belief in the effect before seeing the data. Accordingly, recipients of such an analysis often vary in their prior distributions. Thus, it remains unclear whether they should agree on the claim. Reverse Bayes analysis and the concept of the sufficiently skeptical prior address this problem by asking how strongly one may believe in the absence of an effect in order to be convinced otherwise by the data. To this end, a method called Region of Evidence (RoE) is presented that can be utilized for any normally distributed prior and effect estimate. RoE visualizes the impact of all the prior distributions that, if they were used, would support the claim, including those that a priori favor an effect or its absence. Since RoE only requires an effect estimate and its standard error, it can be easily applied to previously published results. The method incl. its open-source implementation in R and Stata is introduced and its utility is highlighted regarding evidence synthesis in superiority and non-inferiority trials.

The authors declare that they have no competing interests.

The authors declare that an ethics committee vote is not required.